ARTICLES BY THIS AUTHOR
- 8/5/2010
Going Skin Deep-er: Dermatologic toxicities of EGF receptor inhibitors in patients with cancer
Cancer therapies have evolved from conventional cytotoxic chemotherapy to targeted drugs that interfere with specific molecules involved in tumour growth. Targeted drugs that inhibit the epidermal growth factor (EGF) receptor have been successfully tested and are in clinical use for various cancers. Dermatologic toxicity is a unique characteristic of this class of drugs. - 8/5/2010
The dazzling highs and lows of Zion National Park
Walk atop the soaring cliffs or take a measure of your courage in a deep, narrow canyon - 8/5/2010
Barriers to public’s performance of CPR detailed in survey
New education campaign may follow release of refreshed guidelines this fall - 8/5/2010
Ontarians shocked to find some generic prices have risen
Lower pricing doesn’t apply to all generics. - 8/4/2010
Canada ranks near the bottom in usage of newer cancer drugs
New study reinforces need for national catastrophic drug plan for cancer patients: group. - 8/4/2010
CMA overhaul proposal too physician-focused: nurses
Canadian Nurses Association touts wider use of nurse practitioners as cost-effective alternative for easing the physician bottleneck. - 8/4/2010
Living his dream: Taylor Long
- 8/4/2010
Calcium supplements may increase risk of cardiovascular events
A new meta-analysis suggests that calcium supplements (without co-administered vitamin D) are associated with an increased risk of myocardial infarction.